aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with 7432 s in 1 studies
| Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (7432 s) | Trials (7432 s) | Recent Studies (post-2010) (7432 s) |
|---|---|---|---|---|---|
| 253 | 100 | 17 | 235 | 49 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affrime, M; Cutler, D; Lin, CC; Nomeir, A; Radwanski, E | 1 |
1 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and 7432 s
| Article | Year |
|---|---|
Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
Topics: Administration, Oral; Adult; Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Biological Availability; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Humans; Magnesium Hydroxide; Male; Metabolic Clearance Rate; Ranitidine; Simethicone; Time Factors | 1998 |